rs200330326
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000719.7(CACNA1C):c.4944G>A(p.Ala1648Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,510 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000719.7 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5178G>A | p.Ala1726Ala | synonymous_variant | Exon 42 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.4911G>A | p.Ala1637Ala | synonymous_variant | Exon 39 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5109G>A | p.Ala1703Ala | synonymous_variant | Exon 41 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5088G>A | p.Ala1696Ala | synonymous_variant | Exon 42 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5067G>A | p.Ala1689Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5034G>A | p.Ala1678Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5034G>A | p.Ala1678Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5034G>A | p.Ala1678Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5034G>A | p.Ala1678Ala | synonymous_variant | Exon 40 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5028G>A | p.Ala1676Ala | synonymous_variant | Exon 41 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5019G>A | p.Ala1673Ala | synonymous_variant | Exon 41 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5004G>A | p.Ala1668Ala | synonymous_variant | Exon 41 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5001G>A | p.Ala1667Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5001G>A | p.Ala1667Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5001G>A | p.Ala1667Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.4995G>A | p.Ala1665Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.4986G>A | p.Ala1662Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.4968G>A | p.Ala1656Ala | synonymous_variant | Exon 39 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.4968G>A | p.Ala1656Ala | synonymous_variant | Exon 39 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.4962G>A | p.Ala1654Ala | synonymous_variant | Exon 39 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.4944G>A | p.Ala1648Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.4935G>A | p.Ala1645Ala | synonymous_variant | Exon 40 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.4911G>A | p.Ala1637Ala | synonymous_variant | Exon 39 of 46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 247936Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134592
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461188Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 726832
GnomAD4 genome AF: 0.000184 AC: 28AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74478
ClinVar
Submissions by phenotype
CACNA1C-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at